news
QGel raises $12 million to grow mini-organs for drug discovery
The biomaterials company QGel has received $12 million to be used to accelerate QGel’s global expansion and broaden the company "organoids" products.
List view / Grid view
Cancer
news
Oncology collaboration: Proteros & MSD to find epigenetic target
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Proteros has entered into a second research agreement with Merck aimed at developing small molecule compounds against an additional epigenetic target...
article
Rural, poor and sick: The unseen cancer crisis in America
20 October 2016 | By Aaron Yao, PhD, University of Virginia School of Medicine
PhD student Aaron Yao highlights the shocking disparities between rural and urban eastern America and how the odds of cancer survival do not favour the impoverished...
news
IL-34: a new target to tackle chemo-resistant cancer cells
3 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers found that A549-DR was resistant to the chemotherapeutic drug when transplanted in mice, while A549-DR with depleted IL-34 became sensitive...
news
‘Library’ of de-prioritised pharma compounds available for researchers
UK scientists can apply for MRC funding to use any of the compounds in medical research studies to investigate the underlying mechanics of disease...
news
Infra-red light detects early signs of oesophageal cancer
6 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers sprayed a dye on oesophageal tissue samples taken from people with Barrett’s oesophagus – a condition that risk cancer development...
news
New animal model will advance metastasic sarcomas research
30 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Used for the first time as part of the team's latest work, the model may become a valuable experimental tool to analyse metastatic potential in sarcomas...
news
Sea sponge reduces pancreatic tumour size
18 August 2016 | By Niamh Louise Marriott, Digital Content Producer
A deep-water marine sponge collected at Fort Lauderdale's coast contains leiodermatolide, a natural product that inhibits the growth of cancer cells as...
news
Vedanta Biosciences to collaborate on cancer therapies with NYU Langone
16 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The drug development company will collaborate with the research centre on develoing microbiome-derived immunotherapies for cancer patients, to influence the efficacy of checkpoint inhibitors...
news
Secondary tumour, primary killer: How cancer cells destroy blood vessels to form fatal metastases
10 August 2016 | By Max Planck Institute for Heart and Lung Research
The most common cause of cancer deaths is not the primary tumour itself but metastases that subsequently form. Most tumour cells spread via the bloodstream. To do so, individual tumour cells have to enter blood vessels and leave the bloodstream again at remote locations...
news
Veritas cannabis study aims to eliminate chemotherapy side effects
10 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The company 's intends to develop the most effective cannabis strains specific to pain, nausea, epilepsy and PTSD, solving the critical need for real science to support medical marijuana claims...
news
Cancer stem cell collaboration between Plasticell and National University of Ireland
3 August 2016 | By Plasticell
Plasticell has signed a collaboration agreement with the National University of Ireland, Galway (NUI Galway) focused on methods of eradicating cancer stem cells...
news
Targeting Cancer with 5 key spotlight sessions on the latest therapy breakthroughs
21 July 2016 | By SMi Group
SMi's 5th annual Cancer Vaccines event will showcase 5 key spotlight sessions on the latest advances in vaccine development and cancer therapy breakthroughs when it returns to Central London this autumn...
news
A*STAR and MSD team up to advance peptide therapeutics
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
article
Next-generation transcriptomic analysis in cancer vascular research
Over the past decade significant advances have been made in the fields of genomic and transcriptomic profiling, inspired by the advent of next-generation sequencing (NGS). Yet despite the considerable promise of these new technologies, uptake has been slow. The focus of this review is the use of next-generation transcriptomic analysis…